| OEM | OEM Services Provided |
| Feature | Good stability |
| Classification | Chemicals |
| Advantage | Professional, Fast Delivery, Customizable | Samples | Apply for free，Contact Export Director now ↓ |
Flunisine meglumine, a veterinary drug, can relieve inflammation and pain caused by abnormal muscle, relieve internal colic of horses, and treat diarrhea, trembling, colitis, respiratory and other system diseases of foals.,Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
Flunixin meglumine is a non-steroidal anti-inflammatory drug (NSAID) derived from nicotinic acid, primarily used in veterinary medicine for its potent analgesic, anti-inflammatory, and antipyretic effects. It is commonly administered to horses, cattle, and swine for pain and fever management.
| Property | Specification | Test Method |
|---|---|---|
| Chemical Name | 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]nicotinic acid compound with 1-deoxy-1-(methylamino)-D-glucitol | IUPAC nomenclature |
| Molecular Formula | C₁₄H₁₁F₃N₂O₂ · C₇H₁₇NO₅ | Elemental analysis |
| Molecular Weight | 492.48 g/mol (salt form) | Mass spectrometry |
| Appearance | White to off-white crystalline powder | Visual inspection |
| Solubility (25°C) | Freely soluble in water (>100 mg/mL) | USP <911> |
| Melting Point | 150–155°C (decomposes) | DSC analysis |
| Parameter | Value/Description | Reference Standard |
|---|---|---|
| Mechanism of Action | Non-selective COX inhibitor | FDA-CVM guidelines |
| Bioavailability | >80% (IV/IM in horses) | Veterinary PK studies |
| Half-life (t₁/₂) | 1.5–3.5 hours (species-dependent) | Clinical data |
| Protein Binding | >90% | In vitro studies |
| Excretion | Renal (60–70% unchanged) | EMA veterinary reports |
| Species | Indication | Dosage Regimen |
|---|---|---|
| Horses | Musculoskeletal pain, colic | 1.1 mg/kg IV/IM q24h (max 5 days) |
| Cattle | Acute inflammation, fever | 2.2 mg/kg IV/IM single dose |
| Swine | Postoperative pain | 2.2 mg/kg IM q24h (max 3 days) |
| Parameter | Specification |
|---|---|
| Human use status | Not approved (veterinary-only) |
| Withdrawal periods | Cattle: 4 days (meat), 36h (milk) |
| Major adverse effects | GI ulcers, renal toxicity |
| Pregnancy category | Use with caution (avoid late gestation) |
| Environmental impact | Biodegradable (low bioaccumulation) |
| Parameter | Requirement |
|---|---|
| Storage conditions | 15–30°C in original container |
| Shelf life | 36 months (unopened) |
| Light sensitivity | Protect from light |
| Packaging | 100mL sterile vials (50mg/mL) |
| Disposal | Incineration or hazardous waste facility |
Flunixin meglumine is a first-line veterinary NSAID for acute pain and inflammation management, offering rapid onset and reliable efficacy. Strict adherence to species-specific dosing and withdrawal periods is essential to ensure food safety.
Declaration: The products displayed on this website are intended exclusively for industrial applications or scientific research. They are not intended for medical, pharmaceutical, or food use. In accordance with applicable laws and regulations, purchasing organizations must hold valid qualifications and approvals.
For help with solutions customized to your business needs, contact Export Director now.
With 30+ years of experience and We firmly believe that product quality is the basis of cooperation.
Chat Now
TEl
+86-21-6420 0566
